Table 3. Multivariable analysis with OS and EFS in the testing group of 157 CN-AML patients.

Variable	OS, n = 157		EFS, n = 157
	HR (95% CI)	P	HR (95% CI)	P
RUNX1 expression, high VS low	1.56 (1.01–2.41)	0.04	1.65 (1.10–2.48)	0.02
Age, per 10-y increase	1.13 (0.98–1.32)	0.09	1.05 (0.92–1.21)	0.47
Sex male VS female	0.82 (0.54–1.23)	0.33	0.99 (0.67–1.46)	0.96
NPM1, mutated VS wild type	0.51 (0.32–0.81)	0.005	0.53 (0.34–0.83)	0.005
FLT3-ITD, mutated VS wild type	1.98 (1.25–3.14)	0.003	1.85 (1.20–2.85)	0.005
CEBPA, mutated VS wild type	0.71 (0.38–1.35)	0.3	0.78 (0.43–1.41)	0.41

HR, hazards ratio; CI, confidence interval.